Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Definium
Definium's DT120 meets Phase 3 primary endpoint for major depressive disorder

Definium announced positive topline results from the Emerge Phase 3 study, with DT120 ODT demonstrating an 8.1-point placebo-adjusted improvement on t...

Worksport
Worksport achieves 35% May gross margin, lands Meyer Distribution deal

Worksport Ltd announced record 35% gross margin in May 2026, up 660 basis points from Q1, and secured Meyer Distributing as a national distribution pa...

OLENOX
Olenox Industries amends membership interest purchase agreement for CS Digital Ventures acquisition

Olenox Industries amended its membership interest purchase agreement to acquire CS Digital Ventures LLC from multiple members, with Bernardo Schucman ...

RAYONIER
Rayonier Advanced Materials appoints Daniel M. Krawczyk as new CEO

Rayonier Advanced Materials appointed Daniel M. Krawczyk as Chief Executive Officer and President effective immediately. The appointment supports the ...

TUTOR
Tutor Perini proposes $400M senior notes offering due 2033

Tutor Perini Corporation announced a private offering of $400 million in senior notes due 2033, with proceeds to redeem existing 11.875% notes due 202...

Apogee
AbbVie to acquire Apogee Therapeutics in merger agreement dated June 18, 2026

AbbVie Inc. has entered into a definitive merger agreement to acquire Apogee Therapeutics, Inc. through a subsidiary merger structure. The transaction...

CITIZENS
First Citizens Community Bank amends SERP plan for senior executives

First Citizens Community Bank amended its Supplemental Executive Retirement Plan effective June 16, 2026, modifying benefit structures for participati...

Apogee
Apogee enters antibody discovery agreement with Paragon Therapeutics

Apogee Therapeutics signed an Antibody Discovery Agreement with Paragon Therapeutics effective June 17, 2026, for discovery and development of monospe...

Arcosa,
CRH Americas agrees to acquire Arcosa Inc. in merger transaction

CRH Americas and Neon Merger Sub have entered into an Agreement and Plan of Merger to acquire Arcosa Inc., effective June 21, 2026. The transaction co...

LIGAND
Ligand Pharmaceuticals amends credit agreement to permit $700M convertible notes issuance.

Ligand Pharmaceuticals entered into a fourth amendment to its credit agreement with Citibank as administrative agent, consenting to the issuance of up...

AbbVie
AbbVie to acquire Apogee Therapeutics for $10.9 billion in cash

AbbVie announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share, totaling approximately $10.9 billion in equity value. Th...

TOYOTA
Toyota Motor Credit reports $2.3B net income for FY2026, up 35% YoY

TMCC's consolidated net income increased to $2.3 billion in fiscal 2026 from $1.7 billion in fiscal 2025, driven by lower interest expenses and higher...

TScan
TScan reports positive Phase 1 data for TSC-101 in heme malignancy study

TScan Therapeutics announced positive initial data from Cohort C of the ALLOHA Phase 1 study, with 11 of 14 patients achieving complete donor chimeris...

MapLight
MapLight Therapeutics releases Phase 2 IRIS trial topline data for ML-004 in autism

MapLight Therapeutics announced topline data from its Phase 2 IRIS trial evaluating ML-004 for autism spectrum disorder treatment. The clinical trial ...

HawkEye
HawkEye 360 reports Q1 2026 record revenue of $49.8M, up 116.5% YoY

HawkEye 360 achieved record Q1 2026 revenue of $49.8 million with 116.5% year-over-year growth and a $285 million backlog, while completing an IPO tha...

EyePoint,
EyePoint amends 2023 LTIP to increase share reserve by 4.9M shares

EyePoint's board approved Amendment No. 3 to its 2023 Long-Term Incentive Plan, increasing the maximum shares available for equity awards to 15.3 mill...

Fervo
Fervo Energy Reports Q1 2026 Loss, Completes $2.2B IPO

Fervo Energy completed a $2.2 billion IPO in May 2026 and reported a Q1 net loss of $31.8 million while advancing its Cape Station geothermal project ...

CRH
CRH Americas to acquire Arcosa in merger agreement dated June 21, 2026

CRH Americas, Inc. has entered into a definitive merger agreement to acquire Arcosa, Inc. through a merger with Neon Merger Sub, Inc. The transaction ...

MoonLake
MoonLake Reports Strong Week 52 Sonelokimab Results in Phase 3 HS Trials

MoonLake's sonelokimab achieved 67% HiSCR75 response rate and 26% inflammatory remission at Week 52 in hidradenitis suppurativa trials, with BLA submi...

Traws
Traws Pharma to resubmit influenza drug data to MHRA in Q3 2026

Traws Pharma announced it will resubmit an updated toxicology data package for tivoxavir marboxil to the UK's MHRA in Q3 2026 to advance a Phase 2a hu...